Submissions from 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study., Alison Sehgal, Daanish Hoda, Peter A Riedell, Nilanjan Ghosh, Mehdi Hamadani, Gerhard C Hildebrandt, John E Godwin, Patrick M Reagan, Nina D Wagner-Johnston, James Essell, Rajneesh Nath, Scott R Solomon, Rebecca Champion, Edward Licitra, Suzanne Fanning, Neel K Gupta, Victor A Chow, Brenda Yuan, Zhi Yang, Ken Ogasawara, Jerill Thorpe, and Leo I Gordon
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial., Nirav N Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach, William G Wierda, Chaitra S Ujjani, Toby A Eyre, Pier Luigi Zinzani, Alvaro J Alencar, Paolo Ghia, Nicole Lamanna, Marc S Hoffmann, Manish R Patel, Ian Flinn, James N Gerson, Shuo Ma, Catherine C Coombs, Chan Y Cheah, Ewa Lech-Maranda, Bita Fakhri, Won Seog Kim, Minal A Barve, Jonathon B Cohen, Wojciech Jurczak, Talha Munir, Meghan C Thompson, Donald E Tsai, Katherine Bao, Nicholas A Cangemi, Jennifer F Kherani, Richard A Walgren, Hongmei Han, Amy S Ruppert, and Jennifer R Brown
Correction: Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, Steven Coutre, George Follows, Patricia Walker, Karin Karlsson, Paolo Ghia, Ann Janssens, Florence Cymbalista, Jennifer A Woyach, Emmanuelle Ferrant, William G Wierda, Veerendra Munugalavadla, Ting Yu, Min Hui Wang, and John C Byrd
Acalabrutinib-obinutuzumab improves survival vs chemoimmunotherapy in treatment-naive CLL in the 6-year follow-up of ELEVATE-TN., Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, Krish Patel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Marie Hughes, Laura Maria Fogliatto, Yair Herishanu, Versha Banerji, George Follows, Patricia Walker, Paolo Ghia, Ann Janssens, John C Byrd, Emmanuelle Ferrant, Alessandra Ferrajoli, William G Wierda, Catherine Wangui Wachira, Batul T Suterwala, Paulo Miranda, Veerendra Munugalavadla, Chuan-Chuan Wun, and Jennifer A Woyach
Roadmap: medical physics technologies in brachytherapy., William Y Song, Michael Roumeliotis, Junghoon Lee, Aaron Fenster, Jessica Rodgers, Tiana Trumpour, Rachel M Glicksman, Alejandro Berlin, Åsa Carlsson Tedgren, Javier Vijande, Luc Beaulieu, Björn Morén, Sandra Meyers, Alexandra Rink, Yin Gao, Benjamin P Fahimian, Debarghya China, Kai Ding, Tarun K Podder, Eric N Carver, Mark J Rivard, Susan L Richardson, Milan Grkovski, Moeen Meftahi, Ulysses Gardner, Rachit Kumar, Daniel Scanderbeg, Catheryn Yashar, Issam El Naqa, Akila N Viswanathan, and Xun Jia
Consensus recommendations from the 2024 Lymphoma Research Foundation workshop on treatment selection and sequencing in CLL or SLL., Jacob D Soumerai, Jacqueline Barrientos, Inhye Ahn, Catherine Coombs, Douglas Gladstone, Marc Hoffman, Adam Kittai, Ryan Jacobs, Andrew Lipsky, Krish Patel, Joanna Rhodes, Alan Skarbnik, Meghan Thompson, Daniel Ermann, Patrick Reville, Harsh Shah, Jennifer R Brown, and Deborah M Stephens
Pemigatinib for Previously Treated Metastatic or Unresectable Central Nervous System Tumors with FGFR Mutations or Rearrangements: FIGHT-207 Results., Iben Spanggaard, Marc Matrana, Caio Rocha Lima, Amit Mahipal, Maria Vieito, Alice Hervieu, Lipika Goyal, Jordi Rodón, Maria Luisa Veronese, Natalia Oliveira, Xin Li, Michael Schaffer, and Santosh Kesari
Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial., David R Spigel, Virginie Westeel, Ian C Anderson, Laurent Greillier, Florian Guisier, Olivier Bylicki, Firas B Badin, Gaelle Rousseau-Bussac, Clotilde Deldycke, Frank Griesinger, Adam Bograd, Wangjian Zhong, Jacques Le Treut, Sylvie Van Hulst, David R Gandara, Martin Reck, Petra Hoffknecht, Matthew A Gubens, John Crowley, Heiko von der Leyen, Gavitt A Woodard, David M Jablons, Johannes R Kratz, Michael J Mann, and AIM-HIGH investigators
SITC strategic vision: prevention, premalignant immunity, host and environmental factors., Sasha E Stanton, Kristin G Anderson, Tullia C Bruno, Christian M Capitini, Mary L Disis, Jennifer McQuade, Laszlo Radvanyi, Claire Vanpouille-Box, Jennifer Wargo, Kelly J Baines, Megan M Y Hong, Adnan Rajeh, Raymond H Kim, Phillip Awadalla, Lauren K Hughes, and Saman Maleki Vareki
Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy., Alison T Stopeck, Maysa Abu-Khalaf, Virginia Borges, Bartosz Chmielowski, Ruta Rao, Bin Xie, Arkadiusz Z Dudek, Lida Mina, Joyce O'Shaughnessy, Michael Chisamore, Paulette Mattson, Michele Gargano, Joanna Cox, Bruno Osterwalder, Jeremy Drees, Ben Harrison, Anissa S H Chan, Xiaohong Qiu, Nadine Ottoson, Nandita Bose, Mark Uhlik, Jeremy Graff, and Jose Iglesias
Concerted changes in Epithelium and Stroma: a multi-scale, multi-omics analysis of progression from Barrett's Esophagus to adenocarcinoma., Michael K Strasser, David L Gibbs, Philippe Gascard, Joanna Bons, John W Hickey, Deng Pan, Joseph A Caruso, Xianhong Wang, Chira Chen-Tanyolac, Rosemary Bai, Christian M Schürch, Yuqi Tan, Sarah Black, Pauline Chu, Alican Ozkan, Nathan Basisty, Veena Sangwan, Jacob Rose, Samah Shah, Jordan B Burton, Sophie Camilleri-Broet, Pierre Olivier Fiset, Nicholas Bertos, Julie Berube, Haig Djambazian, Rui Li, Spyridon Oikonomopoulos, Daffolyn Rachael Fels Elliott, Sarah Vernovsky, Elee Shimshoni, Deborah Collyar, Ann Russell, Jiannis Ragoussis, Matthew D Stachler, James R Goldenring, Stuart A C McDonald, Donald E Ingber, Birgit Schilling, Garry P Nolan, Thea D Tlsty, Sui Huang, and Lorenzo E Ferri
Off-the-shelf induced pluripotent stem-cell-derived natural killer-cell therapy in relapsed or refractory B-cell lymphoma: a multicentre, open-label, phase 1 study., Paolo Strati, Januario Castro, Aaron Goodman, Veronika Bachanova, Manali Kamdar, Farrukh T Awan, Scott R Solomon, Lilly Wong, Carol Wong, Deepa Patel, Cara Bickers, Wei Zhao, Zahid Bashir, Bahram Valamehr, Rebecca L Elstrom, and Krish Patel
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapy., Ryan J Sullivan, Anthony R Cillo, Robert L Ferris, Russell W Jenkins, Harriet M Kluger, Marleen Kok, Evan J Lipson, Luca Paruzzo, William L Redmond, Marco Ruella, Kurt A Schalper, Daniela S Thommen, Keith Tolley, Mark Yarchoan, and Charlie Garnett-Benson
DRUG AND SINGLE-CELL GENE EXPRESSION INTEGRATION IDENTIFIES SENSITIVE AND RESISTANT GLIOBLASTOMA CELL POPULATIONS., Robert K Suter, Anna M Jermakowicz, Rithvik Veeramachaneni, Matthew D'Antuono, Longwei Zhang, Rishika Chowdary, Simon Kaeppeli, Madison Sharp, Pravallika Palwai, Vasileios Stathias, Grace Baker, Luz Ruiz, Winston Walters, Maria Cepero, Danielle Burgenske, Edward B Reilly, Anatol Oleksijew, Mark G Anderson, Sion Ll Williams, Michael E Ivan, Ricardo J Komotar, Macarena I De La Fuente, Gregory Stein, Alexander Wojcinski, Santosh Kesari, Jann N Sarkaria, Stephan C Schürer, and Nagi G Ayad
A Microfluidic, Multi-Antibody Cell Capture Method to Evaluate Tumor Cells in Cerebrospinal Fluid in Patients With Suspected Leptomeningeal Metastases., Nathan T Sweed, Hao-Ching Hsiao, Barbara Blouw, Tony J Pircher, Deanna Fisher, Katrina Rose Naluz, Julie Ann Mayer, Michael C Dugan, Akanksha Sharma, Jose Carrillo, and Santosh Kesari
Updates on radiotherapy-immunotherapy combinations: Proceedings of 8th Annual ImmunoRad Conference., Fereshteh Talebi, Fabiana Gregucci, Jalal Ahmed, Nir Ben Chetrit, Brian D Brown, Timothy A Chan, Dhan Chand, Julie Constanzo, Sandra Demaria, Dmitry I Gabrilovich, Encouse Golden, Andrew Godkin, Chandan Guha, Gaorav P Gupta, Aisha Hasan, Fernanda G Herrera, Howard Kaufman, Donna Li, Alan A Melcher, Sierra McDonald, Taha Merghoub, Arta M Monjazeb, Sébastien Paris, Sean Pitroda, Anguraj Sadanandam, Dörthe Schaue, Laura Santambrogio, Phillippe Szapary, Julien Sage, James W Welsh, Anna Wilkins, Kristina H Young, Eric Wennerberg, Laurence Zitvogel, Lorenzo Galluzzi, Eric Deutsch, and Silvia C Formenti
Development of a Diagnostic Model for Pancreatic Ductal Adenocarcinoma Using Machine Learning and Blood-Based miRNAs., Jason Y Tang, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy., Kengo Tanigawa and William L Redmond
Does paired genetic testing improve targeted therapy choices and screening recommendations for patients with upper gastrointestinal cancers and their families? A prospective cohort of 42 patients., Kevin Tatunay, Stacey Cohen, Lorraine V Naylor, Cynthia L Handford, Angela Jacobson, Veena Shankaran, Brant Oelschlager, William M Grady, Britta Sjoding, Everett Lally, Lauren Facchini, Qin Sun, Mercy Y Laurino, Colin Pritchard, Eric Q Konnick, and Marianne E Dubard-Gault
Society for Immunotherapy of Cancer: updates and best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) image analysis and data sharing., Janis M Taube, Joel C Sunshine, Michael Angelo, Guray Akturk, Margaret Eminizer, Logan L Engle, Cláudia S Ferreira, Sacha Gnjatic, Benjamin Green, Shirley Greenbaum, Noah F Greenwald, Cyrus V Hedvat, Travis J Hollmann, Daniel Jiménez-Sánchez, Konstanty Korski, Ana Lako, Edwin R Parra, Marlon C Rebelatto, David L Rimm, Scott J Rodig, Jamie Rodriguez-Canales, Jeffrey S Roskes, Kurt A Schalper, Emanuel Schenck, Keith E Steele, Michael J Surace, Alexander S Szalay, Michael T Tetzlaff, Ignacio I Wistuba, Jennifer H Yearley, and Carlo Bifulco
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer., Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Melanie K Bergman, Bhavana Pothuri, Stephen DePasquale, Jennifer M Scalici, Amy J Bregar, Christopher J Darus, Karen Finkelstein, Charles A Leath, Maria Bell, David P Warshal, Richy Agajanian, Megan D Indermaur, Alberto A Mendivil, Diane M Provencher, Lee-Jen Wei, Nicholas Borys, Lauren Musso, Stacy R Lindborg, Douglas V Faller, Khursheed Anwer, and William H Bradley
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191]., Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Melanie Bergman, Bhavana Pothuri, Stephen DePasquale, Jennifer M Scalici, Amy J Bregar, Christopher Darus, Karen Finkelstein, Charles A Leath, Maria Bell, David P Warshal, Richy Agajanian, Megan D Indermaur, Alberto A Mendivil, Diane M Provencher, Lee-Jen Wei, Nicholas Borys, Lauren Musso, Stacy R Lindborg, Douglas V Faller, Khursheed Anwer, and William H Bradley
Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B-Cell Lymphoma., Swetha Kambhampati Thiruvengadam, Reid Merryman, Yan Wang, Charles Gaulin, Evandro Bezerra, Timothy Voorhees, Madhav R Seshadri, Ayo Falade, Alma Habib, Amy A Ayers, Megumi Bailey, Annette Brown, Neil Bailey, Krish Patel, Charalambos B Andreadis, Adam S Kittai, Caron Jacobson, Joycelynne Palmer, Stephen J Forman, Loretta Nastoupil, and Lihua E Budde
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b study., Sara M Tolaney, Komal Jhaveri, Teresa Helsten, Shannon L Puhalla, Alison Conlin, E Claire Dees, Muralidhar Beeram, Sonya C Chapman, Andrew Lithio, Lacey M Litchfield, and Matthew P Goetz
Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1., Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Jasmine Caulfield, Caroline Naomi Valdez, Marta Piecychna, Lin Leng, Michelle E Armstrong, Seamas C Donnelly, Carlo Bifulco, Terri Clister, Rajan P Kulkarni, Lin Zhang, Mario Sznol, Lucia Jilaveanu, Harriet M Kluger, Insoo Kang, and Richard Bucala
Characteristics of patients with liver tumors deemed ineligible for enrollment on Children's Oncology Group trial AHEP1531: An opportunity to expand inclusion criteria and improve outcome., Angela Trobaugh-Lotrario, Allison F O'Neill, Katelyn A Belmonte, Marcio H Malogolowkin, Greg M Tiao, and James I Geller
Multimodal AI generates virtual population for tumor microenvironment modeling., Jeya Maria Jose Valanarasu, Hanwen Xu, Naoto Usuyama, Chanwoo Kim, Cliff Wong, Peniel Argaw, Racheli Ben Shimol, Angela Crabtree, Kevin Matlock, Alexandra Q Bartlett, Jaspreet Bagga, Yu Gu, Sheng Zhang, Tristan Naumann, Bernard A Fox, Bill J. Wright, Ari Robicsek, Brian D. Piening, Carlo Bifulco, Sheng Wang, and Hoifung Poon
Effect of HLA restriction on racial and ethnic disparities in access to immune therapies for advanced synovial sarcoma., Vinayak Venkataraman, Hannah R Abrams, David S Shulman, Elizabeth T Loggers, Seth M Pollack, Kelly G Paulson, and Michael J Wagner
Molecular Correlates of Long-Term Response to Bevacizumab in Glioblastoma., John L Villano, Catherine R Garcia, Rachael M Morgan, Shulin Zhang, Jill Kolesar, Farhan A Mirza, Timothy Samec, Joanne Xiu, Stephanie Rock, Santosh Kesari, Emil Lou, Sonikpreet Aulakh, Michael J Glantz, and Eric T Wong
Outcomes in patients with classic Hodgkin lymphoma refractory or intolerant to brentuximab vedotin and anti-PD-1 therapy: a real world analysis from 15 U.S. academic centers., Timothy J Voorhees, Eric M McLaughlin, Pallawi Torka, Jorge Florindez, Na Hyun Kim, Tamara K Moyo, Heather Reves, Nuttavut Sumransub, Saarang Deshpande, Ashley Rose, Cassandra Duarte, Muhammad Salman Faisal, Showkat Hamid, Suki Subbiah, Sabarish Ayyappan, Lauren Shea, Matt Cortese, Krish Patel, Ajay Major, Hayder Saeed, Jakub Svoboda, Sanjal Desai, Praveen Ramakrishnan Geethakumari, Mehdi Hamadani, Natalie Grover, and Narendranath Epperla
Editorial Expression of Concern: Safety of targeting tumor endothelial cell antigens., Samuel C Wagner, Neil H Riordan, Thomas E Ichim, Julia Szymanski, Hong Ma, Jesus A Perez, Javier Lopez, Juan J Plata-Munoz, Francisco Silva, Amit N Patel, and Santosh Kesari
Developing a novel medulloblastoma diagnostic with miRNA biomarkers and machine learning., Chloe Wang, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Comprehensive Profiling of Acral Lentiginous Melanoma Reveals Downregulated Immune Activation Compared to Cutaneous Melanoma., Stephanie J Wang, Joanne Xiu, Katherine M Butcher, Brittney K DeClerck, Gene H Kim, Justin Moser, Geoffrey T Gibney, Leonel F Hernandez-Aya, Jose Lutzky, Farah Abdulla, Kim A Margolin, Patrícia Abrão Possik, Carla Daniela Robles-Espinoza, Fumito Ito, and Gino K In
Local Tumor Control of Liver Tumors After Histotripsy: A Preliminary National Multicenter Study., Chase J Wehrle, Kevin Burns, Tarub Mabud, Ahmed Sayed Ahmed, Mohamed Alassas, Tiffany Juarez, Jimmy Ton, Jaekeun Kim, Federico Aucejo, Eren Berber, Evan Ong, Mikhail Silk, Brock Hewitt, and David C H Kwon
The first international experience with histotripsy: a safety analysis of 230 cases., Chase J Wehrle, Kevin Burns, Evan Ong, Allison Couillard, Neehar D Parikh, Elaine Caoili, JaeKeun Kim, Federico Aucejo, Andrea Schlegel, Emily Knott, Paul Laeseke, J Philip Boudreaux, Philipp von Breitenbuch, Mikhail Silk, Mohamed Alassas, Andrew Guzowski, Brian Fuller, Erica Knavel Koepsel, Brock Hewitt, Mishal Mendiratta-Lala, and David C H Kwon
Ego networks associated with e-cigarette use among college fraternity students: a cross-sectional study., Allison C Welch, Megan S Patterson, Candice L. Wilshire, Hasmeena Kathuria, Christopher Gilbert, and Jed A Gorden
Community-Based Lung Cancer Screening Program Structure, Quality, and Barriers: The Struggle for Implementation., Candice L Wilshire, Kerrie E Buehler, Claire A Henson, Christopher R Gilbert, and Jed A Gorden
Durability of response of UGN-101: Longitudinal follow up of multicenter study., Solomon L Woldu, Daniel Igel, Brett Johnson, Katie S Murray, Hiroko Miyagi, Wade Sexton, Isamu Tachibana, Hristos Kaimakliotis, Joseph Jacob, Rian Dickstein, Jennifer M Linehan, Alan Nieder, Marc A Bjurlin, Daniel Heidenberg, Mitchell Humphreys, Saum Ghodoussipour, Marcus L Quek, Michael O'Donnell, Brian H Eisner, Surena F Matin, Adam S Feldman, and Yair Lotan
APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence., Jingyi Xie, Daniel G Chen, William Chour, Rachel H Ng, Rongyu Zhang, Dan Yuan, Jongchan Choi, Michaela McKasson, Pamela Troisch, Brett Smith, Lesley Jones, Andrew Webster, Yusuf Rasheed, Sarah Li, Rick Edmark, Sunga Hong, Kim M Murray, Jennifer K Logue, Nicholas M Franko, Christopher G Lausted, Brian Piening, Heather Algren, Julie Wallick, Andrew T Magis, Kino Watanabe, Phil Mease, Philip D Greenberg, Helen Chu, Jason D Goldman, Yapeng Su, and James R Heath
Identification and validation of a T cell receptor targeting KRAS G12V in HLA-A*11:01 pancreatic cancer patients., Xiongfei Xu, Shiwei Guo, Haihui Gu, Zhanshan Cha, Xiaohan Shi, Xiaoyi Yin, Huan Wang, Suizhi Gao, Bo Li, Lingyu Zhu, Wei Jing, Kailian Zheng, Zhuo Shao, Peng Cheng, Chunhong Zheng, Yi-Ping Shih, Yunguang Li, Baohua Qian, Dong Gao, Eric Tran, and Gang Jin
Sensitized mast cells for targeted drug delivery and augmented cancer immunotherapy., Yan Xu, Xiaoge Zhang, Xiao Han, Hanwei Huang, Chaoyang Meng, Yinxian Yang, Tao Sheng, En Ren, Jiaqi Shi, Kaixin He, Dong Cen, Peng Zhao, Weijia Fang, Hongjun Li, Yuqi Zhang, Xiujun Cai, Funan Liu, Jicheng Yu, and Zhen Gu
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer., Noboru Yamamoto, Dong Yan, Vinod Ganju, Xinfang Hou, Hongming Pan, Jianzhen Shan, Liwei Wang, Sang-We Kim, Gary Richardson, Rachel Sanborn, Jingdong Zhang, Ziyong Xiang, Wenjia Wang, Zhe Shi, Ling Zhang, Yaolin Wang, and Rui-Hua Xu
Radiation Induces Pericyte-Myofibroblast Transition., Tomoko Yamazaki, Kelley R Jordan, Nathaniel E Fox, and Kristina H Young
Editorial: Case reports in breast cancer 2023-2024., Fengting Yan, Min Sun, and Henry G Kaplan
Radiation: Keep it Simple, Kim Young
Radiation: Keep it Simple, Kim Young
An Increasing Role for Cytoreductive Surgery in Metastatic Colorectal Cancer-National Trends in the Era of More Effective Systemic Therapy., Stephanie Young, Julia Greene, Daniel P Milgrom, Jessica Weiss, Melanie Goldfarb, and Anton J Bilchik
Impact of Obesity on Postoperative Outcomes in Transanal Total Mesorectal Excision for Rectal Cancer., Makda G Zewde, Daniel K Peyser, Allen T Yu, Antoinette Bonaccorso, Erin Moshier, Karim Alavi, Robert Goldstone, John H Marks, Justin A Maykel, Elisabeth C McLemore, Dana Sands, Scott R Steele, Steven D Wexner, Mark Whiteford, and Patricia Sylla
Digital twin models for predicting venetoclax and azacitidine-induced neutropenia in patients with acute myeloid leukemia., Yue Zhang, Jonathan Martinez, Bahar Tercan, Heikki Kuusanmäki, Frank Emmert-Streib, Jerome G Chandraseelan, Amer Farea, Olli Yli-Harja, Caroline A Heckman, David L Gibbs, Vesteinn Thorsson, Ilya Shmulevich, Mika Kontro, Guangrong Qin, and Boris Aguilar
Machine-learning diagnostics of breast cancer using piRNA biomarkers., Amy R Zhao, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Correction: Natural killer cell infiltration in prostate cancers predict improved patient outcomes., Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patnaik, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, and Emmanuel S Antonarakis
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes., Nicholas A Zorko, Allison Makovec, Andrew Elliott, Samuel Kellen, John R Lozada, Ali T Arafa, Martin Felices, Madison Shackelford, Pedro Barata, Yousef Zakharia, Vivek Narayan, Mark N Stein, Kevin K Zarrabi, Akash Patniak, Mehmet A Bilen, Milan Radovich, George Sledge, Wafik S El-Deiry, Elisabeth I Heath, Dave S B Hoon, Chadi Nabhan, Jeffrey S Miller, Justin H Hwang, and Emmanuel S Antonarakis
Submissions from 2024
Type B Lactic Acidosis: A Very Rare but Fatal Complication of Gastrointestinal Solid Tumor., Fuad I Abaleka, Genanew Bedanie, Diego Olavarria Bernal, Selome F Yewedalsew, and Tasur Seen
Clinical and Multiomic Features Differentiate Young Black and White Breast Cancer Cohorts Derived by Machine Learning Approaches., Kawther Abdilleh, Boris Aguilar, and George Acquaah-Mensah
Combining a complex cancer vaccine with anti-PD-1 and DGK inhibitor Improves therapeutic efficacy and may augment anti-cancer memory development, E Adwani, Brian Fox, and See full list of authors in comments
Nuclear Protein in Testis Carcinoma of the Orbit., Chip Agarwal, Anand Bhatt, and Frank P K Hsu
PRESTO: A Phase III, Open-Label Study of Intensification of Androgen Blockade in Patients With High-Risk Biochemically Relapsed Castration-Sensitive Prostate Cancer (AFT-19)., Rahul Aggarwal, Glenn Heller, David W Hillman, Han Xiao, Joel Picus, Mary-Ellen Taplin, Tanya Dorff, Leonard Appleman, Douglas Weckstein, Akash Patnaik, Alan Bryce, Daniel Shevrin, James Mohler, Daniel Anderson, Arpit Rao, Scott Tagawa, Alan Tan, Susan Halabi, Katharine Dooley, Patrick O'Brien, Ronald Chen, Charles J Ryan, Scott E Eggener, Michael J Morris, EORTC-55994 Study Group, and Brendan Curti (EORTC-55994 Study Group)
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery., Kathy S Albain, Christina Yau, Emanuel F Petricoin, Denise M Wolf, Julie E Lang, A Jo Chien, Tufia Haddad, Andres Forero-Torres, Anne M Wallace, Henry G Kaplan, Lajos Pusztai, David Euhus, Rita Nanda, Anthony D Elias, Amy S Clark, Constantine Godellas, Judy C Boughey, Claudine Isaacs, Debu Tripathy, Janice Lu, Rachel L Yung, Rosa I Gallagher, Julia D Wulfkuhle, Lamorna Brown-Swigart, Gregor Krings, Yunn Yi Chen, David A Potter, Erica Stringer-Reasor, Sarah Blair, Smita M Asare, Amy Wilson, Gillian L Hirst, Ruby Singhrao, Meredith Buxton, Julia L Clennell, Ashish Sanil, Scott Berry, Adam L Asare, Jeffrey B Matthews, Angela M DeMichele, Nola M Hylton, Michelle Melisko, Jane Perlmutter, Hope S Rugo, W Fraser Symmans, Laura J Van't Veer, Douglas Yee, Donald A Berry, and Laura J Esserman
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers., Alain P Algazi, James Moon, Christopher D Lao, Bartosz Chmielowski, Kari L Kendra, Karl D Lewis, Rene Gonzalez, Kevin Kim, John E Godwin, Brendan D. Curti, Michaella Latkovic-Taber, Shirley H Lomeli, Brandon T Gufford, Philip O Scumpia, Roger S Lo, Megan Othus, and Antoni Ribas
Pathologic Features of Esophageal and Gastric Malignancies., Sanaa Al-Nattah, Eduard Matkovic, Michael Schwalbe, and Kristina A Matkowskyj
The doc versus the bot: A pilot study to assess the quality and accuracy of physician and chatbot responses to clinical questions in gynecologic oncology., Mary Katherine Anastasio, Pamela Peters, Jonathan Foote, Alexander Melamed, Susan C Modesitt, Fernanda Musa, Emma Rossi, Benjamin B Albright, Laura J Havrilesky, and Haley A Moss
Using Machine Learning and miRNA for the Diagnosis of Esophageal Cancer., Vishnu A Aravind, Valentina L Kouznetsova, Santosh Kesari, and Igor F Tsigelny
Drug delivery in leptomeningeal disease: Navigating barriers and beyond., Numair Arshad, Nupur Biswas, Jaya Gill, Santosh Kesari, and Shashaanka Ashili
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell Carcinoma., Yuta Asano, Joshua Veatch, Megan McAfee, Jakob Bakhtiari, Bo Lee, Lauren Martin, Shihong Zhang, Francesco Mazziotta, Kelly G Paulson, Thomas M Schmitt, Ariunnaa Munkbhat, Cecilia Young, Brandon Seaton, Daniel Hunter, Nick Horst, Marcus Lindberg, Natalie Miller, Matt Stone, Jason Bielas, David Koelle, Valentin Voillet, Raphael Gottardo, Ted Gooley, Shannon Oda, Philip D Greenberg, Paul Nghiem, and Aude G Chapuis
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer., Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, and Saiama N Waqar
Biological and prognostic relevance of epigenetic regulatory genes in high-grade gliomas., Sonikpreet Aulakh, Joanne Xiu, Andrew Hinton, Sourat Darabi, Michael J Demeure, Soma Sengupta, Santosh Kesari, David M Ashley, Ashley Love Sumrall, Michael J Glantz, and David Spetzler
Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014., Nizar J Bahlis, Christy Samaras, Donna Reece, Michael Sebag, Jeffrey Matous, Jesús G Berdeja, Jesse Shustik, Gary J Schiller, Siddhartha Ganguly, Kevin Song, Christopher S Seet, Mirelis Acosta-Rivera, Michael Bar, Donald Quick, Gustavo Fonseca, Hongjuan Liu, Christian Gentili, Pavit Singh, and David Siegel
A novel small molecule Enpp1 inhibitor improves tumor control following radiation therapy by targeting stromal Enpp1 expression., Jason R Baird, Alejandro F Alice, Roland Saito, Qingqing Chai, Minhua Han, Cindy Ng, Stephanie Han, Beth Fernandez, Sarah Ledoux, Johannes Grosse, Alan J Korman, Megan Potuznik, Venkatesh Rajamanickam, Brady Bernard, Marka R Crittenden, and Michael J. Gough
Genomic and transcriptomic landscape of HER2-low breast cancer., Rani Bansal, Tolulope Adeyelu, Andrew Elliott, Phillip Walker, Matias A Bustos, Estelamari Rodriguez, Melissa K Accordino, Jane Meisel, Margaret E Gatti-Mays, Emily Hsu, Kate Lathrop, Virginia Kaklamani, Matthew Oberley, George Sledge, Sarah L Sammons, and Stephanie L Graff
A Reliable Closure Technique for Retromastoid Craniotomy to Avoid Cerebrospinal Fluid Leaks and Meningitis., Garni Barkhoudarian, R Justin Garling, Regin Jay Mallari, Walavan Sivakumar, and Daniel F Kelly
Endonasal surgery high-risk carotid injury timeout checklist: implementation, institutional protocol and experience., Garni Barkhoudarian, Mehrdad Pahlevani, Seshaan Ratnam, Regin Jay Mallari, Chester Griffiths, and Daniel F Kelly
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk., Daniel R Barnes, Jonathan P Tyrer, Joe Dennis, Goska Leslie, Manjeet K Bolla, Michael Lush, Amber M Aeilts, Kristiina Aittomäki, Nadine Andrieu, Irene L Andrulis, Hoda Anton-Culver, Adalgeir Arason, Banu K Arun, Judith Balmaña, Elisa V Bandera, Rosa B Barkardottir, Lieke P V Berger, Amy Berrington de Gonzalez, Pascaline Berthet, Katarzyna Białkowska, Line Bjørge, Amie M Blanco, Marinus J Blok, Kristie A Bobolis, Natalia V Bogdanova, James D Brenton, Henriett Butz, Saundra S Buys, Maria A Caligo, Ian Campbell, Carmen Castillo, Kathleen B M Claes, Sarah V Colonna, Linda S Cook, Mary B Daly, Agnieszka Dansonka-Mieszkowska, Miguel de la Hoya, Anna deFazio, Allison DePersia, Yuan Chun Ding, Susan M Domchek, Thilo Dörk, Zakaria Einbeigi, Christoph Engel, D Gareth Evans, Lenka Foretova, Renée T Fortner, Florentia Fostira, Maria Cristina Foti, Eitan Friedman, Megan N Frone, Patricia A Ganz, Aleksandra Gentry-Maharaj, Gord Glendon, Andrew K Godwin, Anna González-Neira, Mark H Greene, Jacek Gronwald, Aliana Guerrieri-Gonzaga, Ute Hamann, Thomas V O Hansen, Holly R Harris, Jan Hauke, Florian Heitz, Frans B L Hogervorst, Maartje J Hooning, John L Hopper, Chad D Huff, David G Huntsman, Evgeny N Imyanitov, Louise Izatt, Anna Jakubowska, Paul A James, Ramunas Janavicius, Esther M John, Siddhartha Kar, Beth Y Karlan, Catherine J Kennedy, Lambertus A L M Kiemeney, Irene Konstantopoulou, Jolanta Kupryjanczyk, Yael Laitman, Ofer Lavie, Kate Lawrenson, Jenny Lester, Fabienne Lesueur, Carlos Lopez-Pleguezuelos, Phuong L Mai, Siranoush Manoukian, Taymaa May, Iain A McNeish, Usha Menon, Roger L Milne, Francesmary Modugno, Jennifer M Mongiovi, Marco Montagna, Kirsten B Moysich, Susan L Neuhausen, Finn C Nielsen, Catherine Noguès, Edit Oláh, Olufunmilayo I Olopade, Ana Osorio, Laura Papi, Harsh Pathak, Celeste L Pearce, Inge S Pedersen, Ana Peixoto, Tanja Pejovic, Pei-Chen Peng, Beth N Peshkin, Paolo Peterlongo, C Bethan Powell, Darya Prokofyeva, Miquel Angel Pujana, Paolo Radice, Muhammad U Rashid, Gad Rennert, George Richenberg, Dale P Sandler, Naoko Sasamoto, Veronica W Setiawan, Priyanka Sharma, Weiva Sieh, Christian F Singer, Katie Snape, Anna P Sokolenko, Penny Soucy, Melissa C Southey, Dominique Stoppa-Lyonnet, Rebecca Sutphen, Christian Sutter, Manuel R Teixeira, Kathryn L Terry, Liv Cecilie V Thomsen, Marc Tischkowitz, Amanda E Toland, Toon Van Gorp, Ana Vega, Digna R Velez Edwards, Penelope M Webb, Jeffrey N Weitzel, Nicolas Wentzensen, Alice S Whittemore, Stacey J Winham, Anna H Wu, Siddhartha Yadav, Yao Yu, Argyrios Ziogas, Andrew Berchuck, Fergus J Couch, Ellen L Goode, Marc T Goodman, Alvaro N Monteiro, Kenneth Offit, Susan J Ramus, Harvey A Risch, Joellen M Schildkraut, Mads Thomassen, Jacques Simard, Douglas F Easton, Michelle R Jones, Georgia Chenevix-Trench, Simon A Gayther, Antonis C Antoniou, and Paul D P Pharoah
The Journey to Improve the College of American Pathologists Cancer Biomarker Reporting Protocols., Brett Baskovich, Alexander Baras, Raja R Seethala, Patrick L Fitzgibbons, Frank Schneider, Brent T Harris, and Joseph Khoury
The impact of standardized robotics course training during colorectal surgery fellowship on post-training practice: a survey of graduates., Amir Bastawrous, Hannah Bossie, I-Fan Shih, Yanli Li, Mark Soliman, and Robert K Cleary
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors., Kathryn E Beckermann, Christine M Bestvina, Badi El Osta, Rachel E Sanborn, Hossein Borghaei, Philip Edward Lammers, Giovanni Selvaggi, Jennifer G Whisenant, Ellen Heimann-Nichols, Lynne Berry, Chih-Yuan Hsu, Yu Shyr, Leora Horn, and Heather Wakelee
Cancer Immunotherapy 102, R Brian Bell
From Dysplasia to Advanced Stage Oral Cancer: An Update on Diagnosis and Treatment, R Brian Bell
Updated results from a phase 1/2 study of HPN328, a tri-specific, half-life (T1/2) extended DLL3-targeting T-cell engaged in patients (pts) with small cell lung cancer (SCLC) and other neuroendocrine cancers (NEC), Himisha Beltran, Rachel E Sanborn, and See full list of authors in comments
Artificial intelligence VS human pathology, Carlo Bifulco
Decoding the Tumor Microenvironment with Spatial Biology and AI, Carlo Bifulco
Defining a Quality Specimen: Tissue Requirements and Quality Controls, Carlo Bifulco
Foundational Pathology Models to Drive Personalized Immunotherapies, Carlo Bifulco
Foundation Digital Pathology Models: From Computational Pathology to Spatial Biology, Carlo Bifulco
Other Pathologic Considerations, Carlo Bifulco
Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study., Alexandra J Borst, Whitney Eng, Morgan Griffin, Kiersten W Ricci, Elissa Engel, Denise M Adams, Jillian Dayneka, Sally J Cohen-Cutler, Steven M Andreoli, Melinda D Wu, Allison P Wheeler, Kenneth M Heym, Shelley E Crary, Taizo A Nakano, Rachael R Schulte, Bhuvana A Setty, Thomas W McLean, Kristy S Pahl, Stefanos Intzes, Irina Pateva, Max Teitelbaum, Zili Zong, Yimei Li, and Michael R Jeng
Vandetanib in locally advanced or metastatic differentiated thyroid cancer refractory to radioiodine therapy., Marcia S Brose, Jaume Capdevila, Rossella Elisei, Lars Bastholt, Dagmar Führer-Sakel, Sophie Leboulleux, Iwao Sugitani, Matthew H Taylor, Zhuoying Wang, Lori J Wirth, Francis P Worden, John Bernard, Paolo Caferra, Raffaella M Colzani, Shiguang Liu, and Martin Schlumberger
Adaptation of a Tailored Lung Cancer Screening Decision Aid for People With HIV., Meagan C Brown, Madison Snidarich, Jehan Z Budak, Nicholas Murphy, Nicholas Giustini, Perrin E Romine, Bryan J Weiner, Tanner Caverly, Kristina Crothers, and Matthew Triplette
Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial., Andrea J Bullock, Benjamin L Schlechter, Marwan G Fakih, Apostolia M Tsimberidou, Joseph E Grossman, Michael S Gordon, Breelyn A Wilky, Agustin Pimentel, Daruka Mahadevan, Ani S Balmanoukian, Rachel E Sanborn, Gary K Schwartz, Ghassan K Abou-Alfa, Neil H Segal, Bruno Bockorny, Justin C Moser, Sunil Sharma, Jaymin M Patel, Wei Wu, Dhan Chand, Katherine Rosenthal, Gabriel Mednick, Chloe Delepine, Tyler J Curiel, Justin Stebbing, Heinz-Josef Lenz, Steven J O'Day, and Anthony B El-Khoueiry
Linvoseltamab for Treatment of Relapsed/Refractory Multiple Myeloma., Naresh Bumma, Joshua Richter, Sundar Jagannath, Hans C Lee, James E Hoffman, Attaya Suvannasankha, Jeffrey A Zonder, Mansi R Shah, Suzanne Lentzsch, Rachid Baz, Joseph J Maly, Swathi Namburi, Matthew J Pianko, Jing Christine Ye, Ka Lung Wu, Rebecca Silbermann, Chang-Ki Min, Marie-Christiane Vekemans, Markus Munder, Ja Min Byun, Joaquín Martínez-Lopez, Kaniel Cassady, Michelle DeVeaux, Dhruti Chokshi, Anita Boyapati, Anasuya Hazra, George D Yancopoulos, L Andres Sirulnik, Karen Rodriguez Lorenc, Glenn S Kroog, Yariv Houvras, and Madhav V Dhodapkar
Long-term follow up of E3311, a phase II trial of transoral surgery (TOS) followed by pathology-based adjuvant treatment in HPV-associated (HPV+) oropharynx cancer (OPC): A trial of the ECOG-ACRIN Cancer Research Group, Barbara Burtness and Richard Bryan Bell
Fibula Reconstruction of the Maxilla and Midface., Alita Caldwell, Allen Cheng, Ashish Patel, and Baber Khatib
Sunitinib in Patients With Breast Cancer With, Carmen J Calfa, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Eugene R Ahn, Monika L Burness, Keerthi Gogineni, Nitin Rohatgi, Tareq Al Baghdadi, Alison Conlin, Anu Gaba, Omid Hamid, Jairam Krishnamurthy, Naga Jyothi Gavini, Philip J Gold, Jordi Rodon, Jens Rueter, Ramya Thota, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Rinatabart Sesutecan For Patients With Heavily Pretreated Ovarian Or Endometrial Cancer: Results From The Dose Escalation Cohort Of A Phase 1/2 Study, Justin Call, Ian Anderson, and See full list of authors in comments
Pertuzumab Plus Trastuzumab in Patients With Biliary Tract Cancer With, Timothy L Cannon, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vi K Chiu, Jimmy Hwang, Namrata Vijayvergia, Olatunji B Alese, Elie G Dib, Herbert L Duvivier, Kelsey A Klute, Vaibhav Sahai, Eugene R Ahn, Pablo Bedano, Deepti Behl, Sarah Sinclair, Ramya Thota, Walter Urba, Eddy S Yang, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases., Jose Carrillo, Jaya Mini Gill, Charles Redfern, Ivan Babic, Natsuko Nomura, Dhaval K Shah, Sean Carrick, and Santosh Kesari
Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US., Tara Castellano, Andrew K ElHabr, Christina Washington, Jie Ting, Yitong J Zhang, Fernanda Musa, Ezgi Berksoy, Kathleen Moore, Leslie Randall, Jagpreet Chhatwal, Turgay Ayer, and Charles A Leath
Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database., Michael P Castro, Jameson Quinn, Asher Wasserman, Alaa Awawda, Zachariah D Cole, Mark A Shapiro, Timothy J Stuhlmiller, and Santosh Kesari
